Eosin methylene blue agar
Eosin methylene blue agar is a culture medium used for the isolation and differentiation of Gram-negative bacteria, particularly members of the Enterobacteriaceae family. It is a selective and differential medium that inhibits the growth of Gram-positive bacteria while promoting the growth of Gram-negative bacteria.
Lab products found in correlation
14 protocols using eosin methylene blue agar
Reviving and Culturing MDR Pathogens
Bacterial Contamination Analysis of Contact Lens Cases
Microbial Contamination Evaluation in Food
Pathogen Adhesion Inhibition Assay
adhesion of the pathogen to the HT-29 cell line was evaluated following the
method of Jang et al. (2019) (link). The
confluent HT-29 monolayers were inoculated with 1:1 mixture of pathogenic
bacteria and L. brevis (1×108 CFU/mL) and
incubated at 37°C for 2 h in a CO2 incubator. The prebiotics
(final concentration, 20 mg/mL) were added to each well immediately before
incubation. Samples without LAB or prebiotics were considered as control. To
determine the number (CFU/mL) of pathogens that adhered to the HT-29 cells, the
bacterial cells were harvested with 1% Triton X-100 and serially diluted
in PBS and plated on the Listeria selective agar and eosin methylene blue agar
(Becton-Dickinson, Franklin Lakes, NJ, USA) for detecting L.
monocytogenes and E. coli, respectively. The
plates were incubated at 37°C for 24 h.
Biopsy Tissue Sample Analysis Protocol
Quantifying Wound Bacterial Burden
Separately, the CFU was determined at the 4-h postinoculation time point. The dorsal wounds were removed en bloc by severing the cervical and lumbar spinal column and trimming the tissue at >2 cm beyond the wound edge. The tissue was processed using a sterile homogenizer, and serial 10-fold dilutions were plated via a spiral plater and enumerated as above.
Quantifying Bacterial Burden in Tissues
Monitoring Antibiotic Resistance in Wild Birds
Disk diffusion susceptibility tests (Kirby-Bauer method) were conducted for eight antibiotics: amoxicillin-clavulanic acid (20/10 μg), ampicillin (10 μg), cefotaxime (30 μg), imipenem (10 μg), tetracycline (30 μg), ciprofloxacin (5 μg), colistin (10 μg), and cefoxitin (30 μg). Antibiotic susceptibility results were interpreted following the Clinical and Laboratory Standards Institute guidelines.
Monitoring Antibiotic Resistance in Wild Birds
Disk diffusion susceptibility tests (Kirby-Bauer method) were conducted for eight antibiotics: amoxicillin-clavulanic acid (20/10 μg), ampicillin (10 μg), cefotaxime (30 μg), imipenem (10 μg), tetracycline (30 μg), ciprofloxacin (5 μg), colistin (10 μg), and cefoxitin (30 μg). Antibiotic susceptibility results were interpreted following the Clinical and Laboratory Standards Institute guidelines.
Antimicrobial Resistance Profiling of E. coli
Antimicrobial susceptibility was assessed by determining the minimum inhibitory concentrations (MICs) for 16 antimicrobial agents using the broth microdilution method with a commercially available Sensititre® panel KRVP4F (TREK Diagnostic Systems, West Sussex, UK) according to the manufacturer's instructions. The following antibiotics were tested: ampicillin, amoxicillin/clavulanic acid, cefoxitin, ceftiofur, ceftazidime, cefepime, chloramphenicol, ciprofloxacin, colistin, gentamicin, meropenem, nalidixic acid, streptomycin, sulfisoxazole, tetracycline, and trimethoprim/sulfamethoxazole. The reference strain E. coli ATCC 25922 was used as quality control when determining MICs. The MIC was interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI, 2017). When CLSI breakpoints were not available, the MIC was interpreted according to the Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (DANMAP, 2014). Multidrug resistance was defined as resistance to ≥3 antibiotic subclasses.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!